LIGAND PHARMACEUTICALS INCORPORATED Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
LIGAND PHARMACEUTICALS INCORPORATED (LGNYZ) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $709.52 million as of 2020-12-31, per its 10-K filed 2021-02-24.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2021-02-24
- 2020-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $709.52M.
- 2019-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $767.23M.
- 2018-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $560.91M.
- 2017-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $399.79M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2020-12-31 | $709.52M 10-K · filed 2021-02-24 | |
| 2019-12-31 | $767.23M 10-K · filed 2021-02-24 | |
| 2018-12-31 | $560.91M 10-K · filed 2021-02-24 | |
| 2017-12-31 | $399.79M 10-K · filed 2021-02-24 | |
| 2016-12-31 | $341.29M 10-K · filed 2020-02-27 | |
| 2015-12-31 | $237.28M 10-K · filed 2019-02-28 | $304.39M 10-K · filed 2016-02-26 |
| 2014-12-31 | $24.41M 10-K · filed 2018-03-01 | $49.61M 10-K · filed 2014-12-01 |
| 2013-12-31 | $49.61M 10-K · filed 2017-02-28 | |
| 2012-12-31 | $26.48M 10-K · filed 2016-11-14 | |
| 2011-12-31 | $8.19M 10-K · filed 2015-02-23 | |
| 2010-12-31 | -$4.85M 10-K/A · filed 2014-12-12 | |
| 2009-12-31 | $3.75M 10-K · filed 2013-03-14 |